Back
Curis 10K Form
Sell
48
CRIS
Curis
Last Price:
4.98
Seasonality Move:
-1.23%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-07 | 10Q | CRIS/Curis Quarterly |
| 2023-11-02 | 10Q | CRIS/Curis Quarterly |
| 2023-08-03 | 10Q | CRIS/Curis Quarterly |
| 2023-05-04 | 10Q | CRIS/Curis Quarterly |
| 2022-11-09 | 10Q | CRIS/Curis Quarterly |
| 2022-08-04 | 10Q | CRIS/Curis Quarterly |
Receive CRIS News And Ratings
See the #1 stock for the next 7 days that we like better than CRIS
CRIS Financial Statistics
Sales & Book Value
| Annual Sales: | $10.02M |
|---|---|
| Cash Flow: | $-11.14M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.12 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -8.24000 |
|---|---|
| Net Income (TTM): | $-47.57M |
| Gross Margin: | $9.81M |
| Return on Equity: | -282.32% |
| Return on Assets: | -65.35% |
Curis Earnings Forecast
Key Curis Financial Ratios
- The Gross Profit Margin over the past 24 years for CRIS is 97.88%.
- The Selling, General & Administrative Expenses for CRIS have been equal to 186.04% of Gross Profit Margin.
- The Research & Development expenses have been 394.05% of Revenue.
- The Interest Expense is -4.26% of Operating Income.
- The Net Earning history of CRIS is -473.04% of Total Revenues.
- Per Share Earnings over the last 25 years have been positive in 16 years.
Curis Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CRIS |
| CUSIP: | 231269 |
| Website: | curis.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.78 |
| Quick Ratio: | 1.6 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |